Document Detail

Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment.
MedLine Citation:
PMID:  8880019     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: We studied the relationship between serum C-reactive protein and mortality in acute myocardial infarction. BACKGROUND: Early recanalization of an infarct-related coronary artery is considered to be an essential prerequisite for reducing mortality by thrombolytic treatment in acute myocardial infarction. It also reduces the inflammatory reaction caused by acute myocardial infarction and is measurable by determination of serum C-reactive protein concentrations. We therefore studied the prognostic value of determining serum C-reactive protein in acute myocardial infarction. METHODS: We measured serum C-reactive protein concentrations daily for 6 days and creatine kinase, as well as its MB isoenzyme concentrations twice a day, for 3 days after a myocardial infarct, in 188 consecutive patients selected for thrombolytic therapy and treated in the same University Hospital Coronary Care Unit. The highest serum concentrations were related to total mortality as well as to the causes of death 3, 3-6, 6-12 and 12-24 months after the onset of the myocardial infarction. RESULTS: The highest serum concentrations of serum C-reactive protein were observed 2 to 4 days after the onset of myocardial infarction. The mean value of the highest serum concentration of C-reactive protein in patients who survived the whole 24-month study period was 65 mg. 1(-1), with the 95% confidence intervals for the mean ranging from 58 to 71. The corresponding values in those who died within 3, 3-6, 6-12 and 12-24 months were 166 (139-194), 136 (88-184), 85 (52-119) and 74 (38-111) mg.1(-1), respectively. The values in those who died within 3 and 3-6 months of the infarction differed statistically significantly from the values in those who survived the whole period (P < 0.001 and P < 0.05, respectively). In patients who died due to congestive heart failure the mean highest serum C-reactive protein concentration was 226 (189-265) mg.1(-1). In those who suffered sudden cardiac death and those who died from a new myocardial infarction or non-cardiac causes, the respective values were 167 (138-196), 64 (38-89) and 48 (10-86) mg. 1(-1). The values in those who died due to congestive heart failure and those suffering sudden cardiac death differed statistically significantly (P < 0.001) from the values of those who survived or died due to other causes. The highest serum concentrations of creatine kinase or its MB isoenzyme were not associated with mortality in this study. CONCLUSIONS: High serum C-reactive protein concentrations in acute myocardial infarction patients treated with thrombolytic drugs predict increased mortality up to 6 months following the infarction. Accordingly, reduction of inflammatory reaction by successful thrombolytic treatment may make an important contribution to the survival benefit of thrombolytic treatment of acute myocardial infarction.
K O Pietilä; A P Harmoinen; J Jokiniitty; A I Pasternack
Related Documents :
1212869 - Clinico-biochemical, immunological, and morphological assessment of myocardial inflamma...
1452369 - Serum cortisol levels predict infarct size and patient mortality.
11025249 - Dynamics of serum interleukin-6 level in patients with acute myocardial infarction.
3224449 - Morbidity during five years after myocardial infarction and its relation to infarct size.
9329689 - Serum protein leakage in alzheimer's disease revisited.
7369179 - Rapid drop in serum iron concentration in myocardial infarction.
16253579 - Usefulness of left ventricular diastolic wall motion abnormality as an early predictor ...
16304219 - Intensive care unit readmission after elective coronary artery bypass grafting.
22105869 - Bilateral sensory permanent hearing loss after palliative hypoplastic left heart syndro...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European heart journal     Volume:  17     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  1996 Sep 
Date Detail:
Created Date:  1997-01-30     Completed Date:  1997-01-30     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1345-9     Citation Subset:  IM    
Clinic of Internal Medicine, Tampere University Hospital, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Analysis of Variance
C-Reactive Protein / analysis,  metabolism*
Confidence Intervals
Death, Sudden, Cardiac* / etiology
Follow-Up Studies
Heart Failure / etiology,  mortality*
Middle Aged
Myocardial Infarction / drug therapy,  mortality*,  pathology
Sensitivity and Specificity
Survival Rate
Thrombolytic Therapy*
Time Factors
Reg. No./Substance:
9007-41-4/C-Reactive Protein
Comment In:
Eur Heart J. 1997 Nov;18(11):1834-6   [PMID:  9402460 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients...
Next Document:  Comparison between abnormalities in segmental endocardial motion and abnormalities in segmental wall...